BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35482249)

  • 21. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
    Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
    Front Genet; 2021; 12():721873. PubMed ID: 34408776
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic value of CLIC3 mRNA overexpression in bladder cancer.
    Chen M; Zhang S; Wen X; Cao H; Gao Y
    PeerJ; 2020; 8():e8348. PubMed ID: 31934512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer.
    Ke MJ; Ji LD; Li YX
    Cancer Cell Int; 2020; 20():382. PubMed ID: 32782440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
    PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway.
    Yu R; Li Z; Zhang C; Song H; Deng M; Sun L; Xu L; Che X; Hu X; Qu X; Liu Y; Zhang Y
    PeerJ; 2019; 7():e6885. PubMed ID: 31119084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
    Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
    Front Public Health; 2022; 10():969070. PubMed ID: 36051999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of ferroptosis-related genes for overall survival prediction in breast cancer.
    Jin LY; Gu YL; Zhu Q; Li XH; Jiang GQ
    J Clin Lab Anal; 2021 Dec; 35(12):e24094. PubMed ID: 34741349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
    Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
    Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
    Liang Y; Zhang C; Dai DQ
    World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
    Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
    Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 38. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma.
    Qu C; Ma T; Yan X; Li X; Li Y
    Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.